47 filings
8-K
IMCR
Immunocore Holdings plc
5 Apr 24
Other Events
4:35pm
8-K
IMCR
Immunocore Holdings plc
28 Feb 24
Immunocore reports fourth quarter and full year 2023 financial results and provides a business update
4:19pm
8-K
IMCR
Immunocore Holdings plc
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
8-K
IMCR
Immunocore Holdings plc
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
8-K
IMCR
Immunocore Holdings plc
5 Jan 24
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
7:19am
8-K
r8efh g6n
2 Jan 24
Regulation FD Disclosure
6:25am
6-K
9unsn 9gqmfvgx
7 Nov 23
Current report (foreign)
7:09am
6-K
40h86wy9xhwgepdr0
10 Aug 23
Current report (foreign)
8:28am
6-K
g5w0ig4cnsy
14 Jul 23
Current report (foreign)
4:21pm
6-K
2xg17k09bz99
5 Jun 23
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
9:20am
6-K
25e0dgr
16 May 23
Current report (foreign)
4:00pm
6-K
gt3k0vig ly9p
10 May 23
Current report (foreign)
7:27am
6-K
rtme2k3581gfs9 4hlf5
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
1o195v95az1p1owtn
18 Apr 23
Current report (foreign)
4:13pm
6-K
cc9sjrpfxdp50vv1jf
10 Mar 23
Current report (foreign)
7:00am
6-K
deu x6jqw4y
2 Mar 23
Current report (foreign)
8:15am
6-K
q51f0rkhdst qy
1 Mar 23
Immunocore Reports 2022 Financial Results and Provides Business Update
8:06am
6-K
sij ups5c0gdib9ad
22 Feb 23
Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV
5:25pm
6-K
gdmwxaj 663ggrood
11 Jan 23
Current report (foreign)
4:18pm
6-K
udvnb2ep
9 Jan 23
Immunocore announces strategic priorities including pipeline expansion for 2023 -2024
4:43pm